Corporates x Startups: The Partnership Success Formula

COLLABORATE TO INNOVATE SERIES

CORPORATES X STARTUPS The Success Formula

VERSION: 1.0 DATE: 05 MAY 2025 c LI M E BU R N ERS B AY I N TER N ATION A L AG

WELCOME! Medical device startups face constant challenges, from securing funding to navigating high barriers to entry and complex commercialisation landscapes.

Failure rates are high, but one approach to improving chances of success is establishing effective partnerships.

Startups of any size or development stage have opportunities to partner with larger, established companies.

This guide will help you to understand which type of partnership best suits your startup and how to position your company to attract corporate partners.

In business partnering, I’ve been on both sides of the table as a startup founder and corporate investor. This eBook and related resources available on Meddev Central reflect that experience.

Discover how corporate partnering can transform your startup at any stage — whether you’re just starting out or scaling up, opportunities are always within reach. It’s never too early or too late to unlock growth through strategic partnerships — dive into the eBook and start your journey today!

Sophie

Dr. Sophie Laurenson CEO & Founder MedDev Central

CONTENTS

WELCOME

2

CONTENTS

3

THE SUCCESS FORMULA

4

The right deal

5

The right partner

7

The right person

9

The right message

11

MEDDEV CENTRAL RESOURCES

13

THE SUCCESS FORMULA

Win-win partnerships are characterised by balance, where parties have aligned goals and leverage complementary strengths.

The key is understanding which type of partnership best suits your startup and how to position your company to attract corporate investors.

This tried and tested strategy was developed over more than 20 years of working with large corporations:

THE RIGHT MESSAGE Effective communication is key to securing partnerships. Borrowing from marketing, craft materials that guide stakeholders through structured decision-making using tools like funnels and sales processes.

THE RIGHT DEAL Start-ups and corporations can partner at any stage of the product lifecycle. The key is building a partnership that aligns with your objectives, resources, and capabilities—guided by evidence and strong valuations.

THE RIGHT PARTNER THE RIGHT PERSON Large organisations are complex, and different teams handle different deals. Identifying internal champions—those who believe in your value, have strong networks, and can advocate for you—is critical.

Not all corporations have the strategic fit, financial capacity, or risk appetite for your opportunity. A well-aligned partner is more likely to invest resources, drive progress, and generate long-term value.

THE

RIGHT DEAL

Start-ups and corporations can partner at any stage of the product lifecycle. The key is building a partnership that aligns with your objectives, resources, and capabilities—guided by evidence and strong valuations.

An effective way to approach partnership strategy is to distil the process into three clear and actionable steps: 1. Assess your current position 2. Define your desired future state 3. Identify how various partnership models can help bridge the gap This structured framework provides a practical foundation for startups navigating complex corporate landscapes and building meaningful, valuedriven collaborations.

LEARN MORE

1

ASSESS YOUR CURRENT POSITION A startup maturity assessment evaluates the company’s development stage, asset value, and partnership readiness. Startup–corporate collaborations can happen at any point in the product lifecycle, from ideation to commercialisation, and a company’s maturity and valuation directly influence the types of opportunities available and the terms of engagement. The assessment typically includes: • The current development stage and how completed work contributes to overall value • Available assets—both tangible and intangible—and their current valuation • How those assets are expected to evolve and gain value over time Key milestones such as pre-clinical studies, achieving regulatory approvals, obtaining QMS certification or achieving reimbursement can all drive value at different stages. For early-stage startups, de-risking activities are crucial to increasing valuation at inflexion points. In pre-revenue companies, intangible assets like intellectual property (IP), unique data, brand equity, and relationships with key opinion leaders often carry significant value. These assets can be tracked with simple tools, such as spreadsheets, before transitioning to more advanced systems. Understanding how assets create value over time enables founders to invest strategically, attract the right partners, and track progress. A professional enterprise valuation is essential for companies preparing for equity transactions, such as M&A or venture investment.

2

DEFINE YOUR DESIRED FUTURE STATE Clearly define the objectives of pursuing a corporate partnership. These objectives will shape the type of partners to engage with and the structure of future agreements. Common partnership goals include: • Research and development support • Market access and distribution capabilities • Funding or investment • Regulatory and reimbursement expertise • Access to technology or intellectual property • Credibility and brand alignment To ensure alignment and track progress, it is helpful to translate these goals into clear, measurable outcomes—using frameworks such as SMART (Specific, Measurable, Achievable, Relevant, and Time-bound) criteria.

3

DEFINE YOUR DESIRED FUTURE STATE The final step in the process is to identify which type of partnership can most effectively bridge the gap between your current position and your future goals. This step requires a strategic evaluation of your internal assets and the external opportunities available: •

Aligning partnerships with your growth stage and objectives: There is no universal “ideal” partnership model—each phase of the innovation lifecycle presents different opportunities for collaboration, whether in early development or approaching commercialisation.

•

Identifying key assets to leverage: Use insights from your earlier assessment to determine which tangible or intangible assets can create the most value in a partnership context.

•

Defining a compelling value proposition for partners: This often differs from the messaging crafted for customers or patients. It should highlight the unique strategic value your startup can offer a partner.

•

Reviewing existing obligations: Consider how current agreements, such as investor terms, funding contracts, or prior partnerships, might limit or shape future deals.

•

Prioritising opportunities based on strategic fit: Focus on partnerships that align with your long-term goals and offer mutual value creation.

This step transforms internal readiness into external action, setting the stage for meaningful, highimpact collaborations.

THE

RIGHT PARTNER

Not all corporations have the strategic fit, financial capacity, or risk appetite for your opportunity. A well-aligned partner is more likely to invest resources, drive progress, and generate long-term value.

Common reasons for corporations to partner include: •

Expansion: Partnering with startups enables corporations to diversif y and enter new or niche healthcare markets. This can fill gaps in product portfolios or facilitate entry into adjacent markets.

•

Technology: Collaborating with medical device startups grants corporations access to cutting-edge innovations and fresh perspectives, enabling them to integrate advanced technologies without heavy R&D investment.

•

Intellectual Property: Acquiring or licensing IP from startups offers cost-effective access to new technologies or freedom to operate while minimising financial risk.

•

Vertical Integration: Engaging with startups allows corporations to strengthen control over their supply chain, streamline operations, and enhance efficiency.

LEARN MORE

1

EVALUATING A POTENTIAL CORPORATE PARTNER A partner whose business priorities and capabilities align with your startup’s opportunity is far more likely to commit resources, drive the project forward, and create long-term value.

Before engaging in a partnership, conducting a structured analysis of the potential partner ’s business is essential. This evaluation should cover key strategic, organisational, financial, and operational dimensions to ensure alignment and identify opportunities for collaboration. The following areas provide a foundation for this analysis: •

Strategy: Examine the company ’s mid-term strategy and assess how it aligns with past decisions and broader industry trends. In the medical device sector, a Long-Range Plan (LRP) typically spans five years and provides valuable insight into the company ’s strategic direction.

•

Organisation: Review the corporate structure, including how business units or divisions are organised. Map out key geographic locations, such as R&D and manufacturing sites, and consider the distribution of full-time employees (FTEs) across critical functions. Understanding the company ’s culture is also crucial for evaluating partnership compatibility.

•

Financials: Analyse financial indicators relevant to the partnership context, including revenue, cash flow, R&D investment, and the presence of any corporate venture funds.

•

Product Portfolio & Pipeline: Evaluate the company ’s current product offerings and planned expansions within the scope of the existing LRP and beyond.

•

Partnering History: Investigate the history of the company ’s partnerships, mergers, and acquisitions. Assess how previous collaborations have supported strategic growth and identify any ongoing partnerships that may influence future opportunities.

This structured approach enables startups to determine strategic fit, mitigate risks, and engage more effectively with potential partners.

2

STREAMLINING RESEARCH: KEY TACTICS Identifying the right partner is the most resource-intensive part of corporate partnering.

Public messaging rarely reflects internal reality, and while primary research (e.g. interviews with employees, partners, and analysts) can offer deep insights, it’s costly and time-consuming.

•

Focus on Goal-Relevant Data: Align research with your objectives. For R&D partnerships, prioritise R&D spend, headcount, locations and early-stage deals, not headline financials.

Assess global reach, sales infrastructure, and service capabilities for distribution or marketing deals.

•

Start with Secondary Sources: Use databases and analytics tools for early screening.

These won’t reveal everything, but they help narrow the field before investing in interviews or expert input.

•

Organise Research Effectively: Use tools like MindManager to track and score partners.

Reserve slides for executive summaries; maintain data elsewhere for easier updates.

•

Outsource Strategically: Partner research can be outsourced, but it can be expensive, especially for primary research.

Throughout, refine your approach as new insights emerge. Choosing the wrong partner—lacking commitment or capacity—can lead to delays and lost opportunities.

THE

RIGHT PERSON

Large organisations are complex, and different teams handle different deals. Identifying internal champions—those who believe in your value, have strong networks, and can advocate for you—is critical.

One of the most significant challenges in establishing corporate partnerships is navigating the complexity of large organisations. Success often hinges on identifying and engaging the right stakeholders—each business unit plays a distinct role in evaluating, structuring, and managing different deals.

Connecting with the wrong team can slow progress, dilute your message, or result in missed opportunities altogether.

Corporations typically approach external partnerships and open innovation through various internal functions. Understanding how these functions are organised—and who the key decision-makers are—is critical for building effective relationships. Corporations often use both reactive and proactive strategies to source innovation. Reactive strategies involve assessing inbound partnership requests, while proactive strategies focus on identif ying and pursuing targeted opportunities aligned with strategic priorities.

A successful partnering approach requires more than just knowing the company—it requires knowing who within the company to speak to, and how to align your value proposition with their specific objectives.

LEARN MORE

1

IDENTIFYING AND ENGAGING CORPORATE DECISION-MAKERS Large corporations involve multiple functions in partnering, including: •

Corporate Strategy & Development: Aligns partnerships with long-term business goals and often sponsors strategic collaborations or acquisitions.

•

Business Development and licensing (BD&L): BD&L identifies, evaluates, and negotiates external partnerships that support product development, portfolio expansion, or market entry.

•

Corporate Venture Capital: Invests in startups with high strategic relevance, providing funding and strategic support in exchange for equity.

•

Research and Development (R&D): This department collaborates with startups to research, co-develop or validate new technologies, often contributing technical expertise and infrastructure.

•

Operations: Assesses the feasibility of scaling or integrating startup solutions into existing manufacturing, supply chain, or quality systems.

•

Commercial (e.g. Sales, Marketing, Market Access): Evaluates how a startup’s product can fit into existing channels and customer segments and may co-develop go-to-market strategies.

•

Corporate Social Responsibility (CSR): Partners with startups that align with the company ’s sustainability, equity, or community impact goals.

•

Enabling Functions (Legal, Finance, HR): Manage contracts, compliance, risk, and integration with internal systems to support partnership execution.

For shortlisted partners, analyse organisational structure using annual reports, investor presentations, press releases, and company websites. These often reveal partnership leadership, key priorities, and subsidiary structures. Supplement this with insights from industry contacts, LinkedIn, or platforms like ResearchGate to uncover smaller innovation teams that are not visible in official materials.

2

CONNECTING WITH THE RIGHT PEOPLE After identifying the right teams, the next step is reaching individual decision-makers. It is critical to secure an internal champion—someone who believes in your value and can navigate internal structures. Champions help build momentum and ensure your proposal reaches the right audience.

Effective Tactics for Outreach: •

Warm Introductions: Leverage investors, advisors, and mutual contacts.

•

Industry Events: Attend targeted conferences and networking events.

•

Digital Platforms: Use LinkedIn and ResearchGate to identify relevant contacts.

•

Public Sources: Track press releases, investor calls, and funding databases for partnership mentions and relevant R&D contributors.

To manage outreach, build a structured process similar to a sales funnel. While spreadsheets work for small-scale tracking, CRM tools are more effective for automating contact management and follow-ups, especially in complex, multi-touch interactions.

THE

RIGHT MESSAGE

Effective communication is key to securing partnerships.

Borrowing from marketing, craft materials that guide stakeholders through structured decision-making using tools like funnels and sales processes.

Developing tailored communication materials is essential when building strategic partnerships with corporations. A common misstep many startups make is repurposing their investor pitch deck for corporate audiences.

However, corporate stakeholders have different priorities—focusing more on strategic alignment, risk mitigation, operational fit, and long-term value— making it essential to adapt messaging and materials accordingly.

Think of corporate engagement as a structured marketing campaign that guides stakeholders through a decision-making process from initial interest to formal negotiation. By borrowing tools from marketing and sales, such as engagement funnels and content staging, startups can deliver high-impact materials that build trust, demonstrate credibility, and communicate value.

In the previous section, we introduced a simple engagement funnel for initiating contact with key decision-makers. Here, we’ll expand on that framework to explore how medical device startups can build a more sophisticated corporate engagement funnel, aligned with the four core decision-making stages: Awareness, Consideration, Decision, and Negotiation.

LEARN MORE

CORPORATE PARTNER ENGAGEMENT FUNNEL: FROM AWARENESS TO AGREEMENT Building corporate partnerships follows a staged process, where each phase demands specific content and engagement strategies. Understanding these phases helps startups create targeted outreach that supports long-term, strategic collaborations.

AWARENESS: BUILDING CREDIBILIT Y AND INTEREST

CONSIDERATION: DEMONSTRATING STRATEGIC FIT

DECISION: MITIGATING RISK AND GAINING BUY-IN

NEGOTIATION: STRUCTURING A MUTUALLY VALUABLE DEAL

At the top of the funnel, the goal is to generate awareness and establish credibility. Craft a compelling, tailored value proposition that aligns with the strategic priorities of your target corporations. Share this through multi-channel outreach—industry conferences, email referrals, LinkedIn campaigns, and thought leadership. Prioritise speaking at respected events and publishing in peer-reviewed journals to validate your innovation.

Once you’ve gained attention, the next step is to showcase alignment. Prepare a non-confidential one-pager and slide deck, tailored to highlight how your innovation fits with the target company ’s pipeline and strategic goals. Large corporations may assess thousands of opportunities annually—ensure your materials are clear, concise, and differentiated. Avoid generic claims; instead, focus on evidence of clinical value, market need, and how your solution outperforms current offerings.

As interest grows, engagement typically moves under a Confidential Disclosure Agreement (CDA). This phase involves sharing more detailed information and directly meeting key decision-makers. Be ready to provide targeted data and risk mitigation plans specific to the type of partnership, whether R&D, co-development, or market access. Responsiveness and preparation are key to keeping momentum.

In the final phase, both sides define the structure and terms of the partnership. This could range from a simple research collaboration to a complex M&A or Corporate Venture Investment (CVI). Lighter agreements may only require basic documentation, while larger transactions can involve months of due diligence and legal review. The goal is to achieve a win–win arrangement, balancing strategic value, risk, and long-term potential.

MEDDEV CENTRAL RESOURCES

MASTERCLASS WORKSHOP Startup x Corporate: The Success Formula This 2h virtual masterclass will help you to understand which type of partnership best suits your startup and how to position your company to attract corporate partners.

PARTNERING STRATEGY WORKSHOPS A 1-day strategy workshop designed to provide a strategic framework that helps startups define partnership objectives with intention and clarity. By aligning these objectives with long-term business goals, startups can maximise the value of corporate collaborations and avoid common pitfalls.

ACCELERATOR The MedDev Central Corporate Partnerships Accelerator helps high-potential medical device startups connect with leading corporations, giving you the resources, expertise, and industry connections needed to scale (and probably funding too).

BESPOKE CONSULTING In bespoke consulting projects, we tailor our services to the unique needs and challenges of individual clients to provide targeted solutions that align with the client’s specific goals and circumstances.

Book a consultation

is a division of

meddev-central

@MedDevCentral

@meddev.central

contact@meddevcentral.com

VERSION: 1.0 DATE: 05 MAY 2025 c LI M E BU R N ERS B AY I N TER N ATION AL AG

r/MEDDEVCentral